AmpliSeq for Illumina Myeloid Panel

The Myeloid Panel enables concurrent analysis of both DNA and RNA from blood and bone marrow samples in a single assay to study biomarkers associated with hematologic malignancies. The panel covers relevant targets for these major myeloid disorders: acute myeloid leukemia (AML), myeloid dysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), chronic myeloid leukemia (CML), chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML). Key features include:

High-Value Content

• Targets biomarkers across 69 genes including challenging targets such as CEBPA and FLT3-ITDs

Fast, Streamlined Workflow

• Prepare sequencing-ready libraries in a single day from as little as 10 ng high-quality DNA and RNA

Accurate Data

• Detect somatic mutations down to 5% frequency using local or cloud-based analysis

The Myeloid Panel is part of an integrated workflow that includes AmpliSeq for Illumina polymerase chain reaction (PCR)-based library preparation, Illumina sequencing by synthesis (SBS), NGS technology, and automated analysis.

The ready-to-use panel saves you the time and effort of identifying targets, designing primers, and optimizing panels.

Learn More About AmpliSeq for Illumina